Wedge resection for early-stage ground-glass lung nodules
Part of Cancer, Lungs & breathing clinical trials.
This study compares a less invasive surgery (wedge resection) for early-stage lung cancer that appears as a ground-glass nodule on CT scans. The goal is to see if this approach works as well as standard surgery while preserving more healthy lung tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are in good physical health (able to do light work or be fully active).
- You have not had lung cancer surgery before.
- You have not had chemotherapy or radiation therapy for lung cancer before.
- Your CT scan shows a small lung nodule (2 cm or smaller) that is mostly a faint shadow (ground-glass) with only a small solid part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to heat and destroy lung nodules without surgery: one uses computer guidance (robotic navigation) and the other uses CT scans to guide the treatment. If you have an early-stage lung cancer that you can't or don't want to have removed surgically, this study may help find a less invasive option.
This study compares a lung surgery approach (segmentectomy) for people with early, invasive lung cancer that shows “ground-glass” on scans. It aims to see if this less extensive surgery can treat the cancer effectively when the tumor is in a specific size and scan pattern range.
This study looks at whether people with a very early type of lung cancer can safely have curative surgery when their CT scan shows a ground-glass type spot with certain size and shape measurements. It aims to help doctors choose the right surgery approach based on the scan features and final pathology.
This trial is testing a lung-sparing surgery called segmentectomy for people with a certain type of lung cancer nodule. It aims to see if this surgery is a good option for those with solid-dominant nodules that are 2 to 3 cm in size and have not spread to lymph nodes.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This study compares two types of lung cancer surgery — removing only the part of the lung with the tumor (segmentectomy) versus removing the entire lobe (lobectomy) — for patients with early-stage lung cancer that is 2-3 cm. The goal is to see if the smaller surgery works just as well while preserving more lung function.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.